Finance

Lists
Why is VTGN down 2.92%?
Dive Deeper
VTGN:NASDAQ
Vistagen Therapeutics Inc
$0.23
-2.92%
(-0.0070) 1D
$0.23
+0.04% (+0.00010)
Pre-market
Closed: Sep 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTGN...
Open
$0.24
High
$0.24
Low
$0.23
Mkt. cap
10.34M
Avg. vol.
728.09K
Volume
1.78K
52-wk high
$5.14
52-wk low
$0.20
EPS
-$1.68
Beta
0.39
Shares outstanding
44.38M
No. of employees
41
Open
$0.24
High
$0.24
Low
$0.23
Mkt. cap
10.34M
Avg. vol.
728.09K
Volume
1.78K
52-wk high
$5.14
52-wk low
$0.20
EPS
-$1.68
Beta
0.39
Shares outstanding
44.38M
No. of employees
41
About Vistagen Therapeutics Inc
CEO-
Employees41
Founded1998
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitevistagen.com
Analyst ratings
Based on 2 analysts giving stock ratings to VTGN in the past 3 months
Hold
Buy
0
Hold
2
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for VTGN in the last 3 months.
Highest
Current $0.23
$1.00 (+329.18%)
Average
$1.00 (+329.18%)
Lowest
$1.00 (+329.18%)
Analyst
Recommendation
Action
Price target
Projected
Date
Myles Minter
William Blair
Hold
Maintained
-
-
08/14/2026
Paul Matteis
Stifel Nicolaus
Hold
Maintained
$1.00
+329.2%
07/06/2026
Andrew Tsai
Jefferies
Hold
Downgraded
$0.90
+286.3%
12/17/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
258.00K
303.00K
465.00K
1.48M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15.92M
14.22M
13.06M
10.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.40M
5.63M
4.12M
3.92M
Operating expense
20.31M
19.85M
17.18M
14.82M
Total operating expenses
20.31M
19.85M
17.18M
14.82M
Operating income
-20.05M
-19.55M
-16.72M
-13.35M
Other non operating income
6.00K
-
-2.00K
-1.00K
EBT including unusual items
-19.42M
-18.90M
-16.27M
-13.03M
EBT excluding unusual items
-19.42M
-18.90M
-16.27M
-13.03M
Income tax expense
-
-
7.00K
-
Effective tax rate
-
-
-0.04%
-
Other operating expenses
-
-
-
-
Net income
-19.42M
-18.90M
-16.27M
-13.03M
Net profit margin
-7,525.97%
-6,237.29%
-3,499.78%
-882.79%
Earnings per share
-0.54
-0.45
-0.37
-0.30
Interest and investment income
630.00K
647.00K
452.00K
319.00K
Interest expense
-
-
-
-
Net interest expenses
630.00K
647.00K
452.00K
319.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.00M
-19.49M
-16.66M
-13.30M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps